Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 2004

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Mifepristone versus the Yuzpe regimen (PC4) for emergency contraception.

AUTHORS

Ashok PW; Hamoda H; Flett GM; Templeton A

SOURCE

International Journal of Gynecology and Obstetrics. 2004 Nov;87(2):188-193.

ABSTRACT

The objective was to compare side effects, women's acceptance and satisfaction with mifepristone (100 mg) versus

the Yuzpe regimen for emergency contraception (EC). A total of 1000 women requesting EC within 72 h of

unprotected intercourse were randomized to receive mifepristone 100 mg or the standard Yuzpe regimen. Outcome

measures included patient acceptability and satisfaction. A total of 620 (62%) questionnaires were returned, 64% in

the mifepristone group and 60% in the Yuzpe group. Mifepristone was better tolerated than the Yuzpe regimen. The

rates of nausea (P < 0.0001), abdominal pain (P = 0.001), tiredness (P < 0.0001), lethargy (P = 0.001), hot flushes (P

< 0.0001) and dizziness (P < 0.0001) were all significantly higher in women given the Yuzpe regimen compared to

those who received mifepristone. Of these 94% and 80% in the mifepristone and Yuzpe groups, respectively, were

satisfied with treatment (P < 0.0001). Of women in the mifepristone group, 56% (181/321) had used the Yuzpe

regimen of EC in the past and of these, 93.6% (161/172) indicated they would use mifepristone in the future. A total

of four women in the Yuzpe group had mifepristone in the past and all four said they would use mifepristone in the

future. Mifepristone has high patient acceptability and few side effects compared to the standard Yuzpe regimen for

EC. (PubHealth.info Document ID: CONT1T 588-06)

PubHealth.info NOTE: The author(s) of this article titled, "Mifepristone versus the Yuzpe regimen (PC4) for emergency

contraception.", is(are) Ashok PW; Hamoda H; Flett GM; Templeton A. The source of this article is "International

Journal of Gynecology and Obstetrics. 2004 Nov;87(2):188-193.". This article was published in 2004 in English

language(s). (PubHealth.info® Document ID: CONT1T 588-06. All rights reserved with PubHealth.info) PIN: 588

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.